Journal profile · Medicine-Pediatrics, Perinatology and Child Health
Current Treatment Options in Pediatrics
ISSN 2198-6088 · Springer Nature · 4 issues per year
Current Treatment Options in Pediatrics: subscription journal; APC about USD 4,090; median 50 days to acceptance (45 articles, last 24 months); 36 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Current Treatment Options in Pediatrics is published by Springer Nature. By OpenAlex counts of its recent articles, its largest topics are Pediatric Urology and Nephrology Studies, Congenital Heart Disease Studies and Urological Disorders and Treatments, together about 27.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Current Treatment Options in Pediatrics aims to review the most important, recently published research on treatment in the field of pediatrics. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of children of all ages.We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas covering all the major medical and surgical disciplines in pediatrics. Section Editors, in turn, select topics for which leading experts contribute comprehensive treatment-focused review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also occasionally provided.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pediatrics, Perinatology and Child Health
Editor-in-chief Charles ChenPublisher website
Editorial board by country: none in mainland China; most named United States 15, South Africa 1, Argentina 1 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pediatric Urology and Nephrology StudiesMedicine10.6%
- Congenital Heart Disease StudiesMedicine10.3%
- Urological Disorders and TreatmentsMedicine6.7%
- Healthcare Quality and ManagementHealth Professions6.7%
- Patient Safety and Medication ErrorsHealth Professions5.9%
- Gastrointestinal motility and disordersMedicine4.9%
- Urinary Bladder and Prostate ResearchMedicine4.2%
- Infant Development and Preterm CareMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pediatrics, Perinatology and Child Health | Q3 | 223/351 | 36th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.1LetPub ·
- SJR 2026-06
- 0.24LetPub ·
- SNIP 2026-06
- 0.41LetPub ·
- h-index
- 18OpenAlex ·
- i10-index
- 52OpenAlex ·
- 2-year mean citedness
- 1.3OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 131,300Publisher website ·
Articles by year OpenAlex count · 389 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 33 | 17 | 278 |
| 2025 | 36 | 19 | 298 |
| 2024 | 31 | 10 | 286 |
| 2023 | 28 | 2 | 213 |
| 2022 | 29 | 8 | 220 |
| 2021 | 16 | 3 | 220 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
50 daysMedian, submission to acceptance · P25–P75 28 days – 88 days
- Acceptance to online
- median 24 days (72 articles)
- Submission to online
- median 89 days
- Sample
- 45 articles with submission and acceptance dates (78 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 7 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,090 / EUR 3,090 / GBP 2,690 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted2
- commentaryReview Articles and Invited Commentaries. Back to topLength not stated
- review articleReview Articles and Invited Commentaries. Back to topLength not stated
Policy excerpts from the journal's websiteAI use, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access
- AI use Generative AI Images
LLMs do not satisfy authorship criteria; AI-assisted copy editing need not be declared but generative editorial work must be documented. Model summary
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Conflicts of interest Conflict of interest
Authors are required to disclose financial or non-financial interests directly or indirectly related to the submitted work. Model summary
All benefits in any form from a commercial party related directly or indirectly to the subject of this manuscript or any of the authors must be acknowledged. For each source of funds, both the research funder and the grant number should be given. This note should be added in a separate section before the reference list. If no conflict exists, authors should state: The authors declare that they hav…
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement explaining how to access supporting data, including links/citations to publicly archived datasets. Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics
Journal follows COPE guidelines on publication ethics and misconduct. Model summary
This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
Open Choice articles retain copyright with the author and are published under a Creative Commons license. Model summary
To find out more about publishing your work Open Access in Current Treatment Options in Pediatrics, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 2198-6088
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Treatment Options in Pediatrics
How long does peer review take at Current Treatment Options in Pediatrics?
Based on the dates recorded on 45 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 50 days (interquartile range 28–88 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Treatment Options in Pediatrics?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current Treatment Options in Pediatrics based?
Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (15), South Africa (1) and Argentina (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Treatment Options in Pediatrics?
According to LetPub and DOAJ records, Current Treatment Options in Pediatrics is indexed in Scopus. The journal's website also lists Embase; that list has not been checked against each database.
Is Current Treatment Options in Pediatrics open access, and what is the APC?
Current Treatment Options in Pediatrics is a subscription journal. APC about USD 4,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .